Agilent Technologies, Inc. (A)
After hours:
| Previous Close | 139.97 |
| Open | 139.35 |
| Bid | 137.36 x 1100 |
| Ask | 137.60 x 800 |
| Day's Range | 137.26 - 139.73 |
| 52 Week Range | 112.52 - 179.57 |
| Volume | |
| Avg. Volume | 1,627,480 |
| Market Cap | 40.736B |
| Beta (5Y Monthly) | 1.06 |
| PE Ratio (TTM) | 33.81 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.84 (0.59%) |
| Ex-Dividend Date | Jul 01, 2022 |
| 1y Target Est | N/A |
- Business Wire
Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results
SANTA CLARA, Calif., August 16, 2022--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.72 billion for the third quarter ended July 31, 2022, an increase of 8% compared to the third quarter of 2021 and up 13% on a core(1) basis.
- Business Wire
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
SANTA CLARA, Calif., August 02, 2022--Agilent Technologies has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization.
- Business Wire
Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)
SANTA CLARA, Calif., August 02, 2022--Agilent Technologies Inc. (NYSE: A) today announced that Professor Gerhardt Attard has been selected to receive a prestigious Agilent Thought Leader Award. Prof Attard is a John Black Charitable Foundation Endowed Chair in Urological Cancer Research at University College London (UCL). Professor Attard is prominent for his innovative research and clinical trials using cutting-edge liquid biopsy technologies to identify biomarkers to monitor drug response and
